Advertisement

Current Atherosclerosis Reports

, Volume 6, Issue 6, pp 441–446 | Cite as

Omega-6 fatty acids and coronary artery disease: The pros and cons

  • Gal Dubnov
  • Elliot M. Berry
Article

Abstract

Polyunsaturated fatty acids have long been recommended as a beneficial substitute for atherogenic saturated fat. The connection between dietary lipids and blood cholesterol is still under debate, as is the connection between dietary fat and coronary artery disease. Thus, the lipid hypothesis is still a hypothesis. The major dietary polyunsaturated fatty acid, linoleic acid of the omega-6 family, has several properties that render it hyperinsulinemic and atherogenic. The potential benefits of linoleic acid intake regarding coronary artery disease, and its possible harms, are discussed.

Keywords

Coronary Artery Disease Polyunsaturated Fatty Acid Dietary Fatty Acid Dietary Linolenic Acid Coronary Artery Disease Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Calder PC: Fatty acid metabolism and eicosanoid synthesis. Clin Nutr 2001, 20 (suppl 4):1–5.Google Scholar
  2. 2.
    Singh RB, Dubnov G, Niaz MA, et al.: Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet 2002, 360:1455–61.PubMedCrossRefGoogle Scholar
  3. 3.
    de Lorgeril M, Salen P, Martin JL, et al.: Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation 1999, 99:779–85.PubMedGoogle Scholar
  4. 4.
    GISSI - Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999, 354:447–55.CrossRefGoogle Scholar
  5. 5.
    Yam D, Eliraz A, Berry EM: Diet and disease- the Israeli paradox: possible dangers of a high omega 6 polyunsaturated fatty acid diet. Isr J Med Sci 1996, 32:1134–43.PubMedGoogle Scholar
  6. 6.
    Dubnov G, Berry EM: Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet 2003, 92:81–91.PubMedGoogle Scholar
  7. 7.
    Pella D, Dubnov G, Singh RB, et al.: Effects of an Indo-Mediterranean diet on the omega-6/omega-3 ratio in patients at high risk of coronary artery disease: the Indian paradox. World Rev Nutr Diet 2003, 92:74–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Raheja BS, Sadikot SM, Phatak RB, Rao MB: Significance of the n-6/n-3 ratio for insulin action in diabetes. Ann NY Acad Sci 1993, 683:258–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Pearson TA, Mensah GA, Alexander RW, et al.: Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499–511.PubMedCrossRefGoogle Scholar
  10. 10.
    Bloomgarden ZT: Inflammation and insulin resistance. Diab Care 2003, 26:1619–23, 1922–6.CrossRefGoogle Scholar
  11. 11.
    Ross R: Atherosclerosis—an inflammatory disease. N Engl J Med 1999, 340:115–26.PubMedCrossRefGoogle Scholar
  12. 12.
    Dwyer JH, Allayee H, Dwyer KM, et al.: Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004, 350:29–37.PubMedCrossRefGoogle Scholar
  13. 13.
    Cipollone F, Toniato E, Martinotti S, et al.: A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004, 291:2221–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Ordovas JM, Corella D, Demissie S, et al.: Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 2002, 106:2315–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Cunnane SC: Problems with essential fatty acids: time for a new paradigm? Prog Lipid Res 2003, 42:544–68.PubMedCrossRefGoogle Scholar
  16. 16.
    Simopoulos AP, Leaf A, Salem N: Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 1999, 43:127–130.PubMedCrossRefGoogle Scholar
  17. 17.
    Keys A, Parlin RW: Serum cholesterol response to changes in dietary lipids. Am J Clin Nutr 1966, 19:175–81.PubMedGoogle Scholar
  18. 18.
    Keys A, Anderson JT, Grande F: Serum cholesterol response to changes in diet, IV: particular saturated fatty acids in the diet. Metabolism 1965, 14:776–787.CrossRefGoogle Scholar
  19. 19.
    Hegsted DM, McGandy RB, Myers ML, et al.: Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965, 17:281–295.PubMedGoogle Scholar
  20. 20.
    Kannel WB, Dawber TR, Friedman GD, et al.: Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease; the Framingham study. Ann Intern Med 1964, 61:888–99.PubMedGoogle Scholar
  21. 21.
    Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971, 741–12.Google Scholar
  22. 22.
    Berry EM, Hirsch J, Most J, et al.: The relationship of dietary fat to plasma lipid levels as studied by factor analysis of adipose tissue fatty acid composition in a free-living population of middle aged American men. Am J Clin Nutr 1986, 44:220–31.PubMedGoogle Scholar
  23. 23.
    Dixon LB, Ernst ND: Choose a diet that is low in saturated fat and cholesterol and moderate in total fat: subtle changes to a familiar message. J Nutr 2001, 131:510S-526S.PubMedGoogle Scholar
  24. 24.
    Djousse L, Pankow JS, Eckfeldt JH, et al.: Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2001, 74:612–619.PubMedGoogle Scholar
  25. 25.
    Oomen CM, Ocke MC, Feskens EJ, et al.: Alpha-linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr 2001, 74:457–63.PubMedGoogle Scholar
  26. 26.
    Iso H, Sato S, Umemura U, et al.: Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002, 33:2086–2093.PubMedCrossRefGoogle Scholar
  27. 27.
    Ravnskov U: The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998, 51:443–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Hooper L, Summerbell CD, Higgins JPT, et al.: Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 2001, 322:757–63.PubMedCrossRefGoogle Scholar
  29. 29.
    Djousse L, Folsom AR, Province MA, et al.: Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2003, 77:819–25.PubMedGoogle Scholar
  30. 30.
    He K, Merchant A, Rimm EB, et al.: Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ 2003, 327:777–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Kris-Etherton P, Daniels SR, Eckel RH, et al.: Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation 2001, 103:1034–9.PubMedGoogle Scholar
  32. 32.
    World Health Organization: Diet, Nutrition, and the Prevention of Chronic Diseases. Technical report No. 916. Geneva: World Health Organization; 2003.Google Scholar
  33. 33.
    Grundy AM: Evaluation of Publicly Available Scientific Evidence Regarding Certain Nutrient-Disease Relationships: Lipids and Cardiovascular Disease. Bethesda, MD: Life Sciences Research Office. Federation of American Societies for Experimental Biology; 1991.Google Scholar
  34. 34.
    Berry EM: Are diets high in omega 6 polyunsaturated fatty acids unhealthy? Eur Heart J Supplements 2001, 39 (suppl D): D37-D41.CrossRefGoogle Scholar
  35. 35.
    Berry EM: Who’s afraid of n-6 polyunsaturated fatty acids? Methodological considerations for assessing whether they are harmful. Nutr Metabol Cardiovasc Dis 2001, 11:181–188.Google Scholar
  36. 36.
    Okuyama H, Kobayashi T, Watanabe S: Dietary fatty acids—the n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog Lipid Res 1997, 35:409–457.CrossRefGoogle Scholar
  37. 37.
    Rose GA, Thomson WB, Williams TR: Corn oil in treatment of ischaemic heart disease. BMJ 1965, 1:1531–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Pearce ML, Dayton S: Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet 1971, 1:464–7.PubMedGoogle Scholar
  39. 39.
    Kark JD, Kaufmann NA, Binka F, et al.: Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 2003, 77:796–802.PubMedGoogle Scholar
  40. 40.
    Lardinois CK, Starich GH, Mazzaferri EL, DeLett A: Polyunsaturated fatty acids augment insulin secretion. J Am Coll Nutr 1987, 6:507–15.PubMedGoogle Scholar
  41. 41.
    Konard RJ, Stoller JZ, Gao ZY, Wolf BA: Eicosapentaenoic acid (C20:5) augments glucose-induced insulin secretion from beta-TC3 insulinoma cells. Pancreas 1996, 13:253–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Beysen C, Karpe F, Fielding BA, et al.: Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 2002, 45:1533–41.PubMedCrossRefGoogle Scholar
  43. 43.
    Reaven GM: Role of insulin resistance in human disease. Diabetes 1988, 37:1595–1607.PubMedCrossRefGoogle Scholar
  44. 44.
    Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229–34.PubMedCrossRefGoogle Scholar
  45. 45.
    Jenkinson A, Franklin MF, Wahle K, Duthie GG: Dietary intakes of polyunsaturated fatty acids and indices of oxidative stress in human volunteers. Eur J Clin Nutr 1999, 53:523–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Dubnov G, Berry EM: Polyunsaturated fatty acids, insulin resistance, and atherosclerosis: is inflammation the connecting link? Metabol Synd Related Disord 2004, In press.Google Scholar
  47. 47.
    Steinberg D, Parthasarathy S, Carew TE, et al.: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989, 320:915–24.PubMedCrossRefGoogle Scholar
  48. 48.
    Kratz M, Cullen P, Kannenberg F, et al.: Effects of dietary fatty acids on the composition and oxidizability of low density lipoprotein. Eur J Clin Nutr 2002, 56:72–81.PubMedCrossRefGoogle Scholar
  49. 49.
    Berry EM, Eisenberg S, Haratz D, et al.: Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins--the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr 1991, 53:899–907.PubMedGoogle Scholar
  50. 50.
    Harper CR, Jacobson TA: The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001, 161:2185–92.PubMedCrossRefGoogle Scholar
  51. 51.
    Pischon T, Hankinson SE, Hotamisligil GS, et al.: Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108:155–60.PubMedCrossRefGoogle Scholar
  52. 52.
    Landmesser U, Hornig B, Drexler H: Endothelial function: a critical determinant in atherosclerosis? Circulation 2004, 109(21 Suppl 1):II27-II33.PubMedGoogle Scholar
  53. 53.
    Toborek M, Lee YW, Garrido R, et al.: Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr 2002, 75:119–25.PubMedGoogle Scholar
  54. 54.
    Larsen LF, Jespersen J, Marckmann P: Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently. Am J Clin Nutr 1999, 70:976–82.PubMedGoogle Scholar
  55. 55.
    Kang JX, Leaf A: Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci 1994, 91:9886–90.PubMedCrossRefGoogle Scholar
  56. 56.
    Li Y, Kang JX, Leaf A: Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. Prostaglandins 1997, 54:511–30.PubMedCrossRefGoogle Scholar
  57. 57.
    Harrell MD, Stimers JR: Differential effects of linoleic acid metabolites on cardiac sodium current. J Pharmacol Exp Ther 2002, 303:347–55.PubMedCrossRefGoogle Scholar
  58. 58.
    Pan M, Cederbaum AI, Zhang YL, et al.: Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 2004, 113:1277–87.PubMedCrossRefGoogle Scholar
  59. 59.
    Cunnane SC: Commentary on the workshop statement. Essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2000, 63:139–44.PubMedCrossRefGoogle Scholar
  60. 60.
    Horrobin DF: Commentary on the workshop statement: are we really sure that arachidonic acid and linoleic acid are bad things? Prostaglandins Leukot Essent Fatty Acids 2000, 63:145–7.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Gal Dubnov
    • 1
  • Elliot M. Berry
    • 1
  1. 1.Department of Human Nutrition and Metabolism, Braun School of Public HealthHebrew University-Hadassah Medical SchoolJerusalemIsrael

Personalised recommendations